Daiichi Sankyo
- All
- News
- Videos
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
Singh Brothers, Ex-Ranbaxy Promoters, Guilty Of Contempt: Supreme Court
Ex-Ranbaxy promoters Malvinder Singh and his brother Shivinder Singh have been held guilty by the Supreme Court of contempt of court in a case filed by Japanese firm Daiichi Sankyo.
-
"Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
-
Fortis Co-Founder Shivinder Singh Sues Elder Brother For "Mismanagement"
Billionaire Shivinder Mohan Singh, co-founder of hospital chain Fortis Healthcare and former Ranbaxy promoter, has filed a case against his elder brother Malvinder Mohan Singh alleging "oppression and mismanagement" at their joint businesses - RHC Holding, Religare and Fortis.
-
Daiichi Sankyo Asks ED To Probe Singh Brothers' Transactions: A Timeline
Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.
-
Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal
Mumbai-based Sun Pharma will acquire troubled Indian drug maker Ranbaxy in a US$ 4 billion all-stock transaction, the company said in a statement on Monday.
-
Ranbaxy, Teva settle New York antitrust drug claims
Generic drug makers Ranbaxy of India and Teva of Israel have agreed to settle allegations they made an illegal pact to restrict competition in New York state.
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
Singh Brothers, Ex-Ranbaxy Promoters, Guilty Of Contempt: Supreme Court
Ex-Ranbaxy promoters Malvinder Singh and his brother Shivinder Singh have been held guilty by the Supreme Court of contempt of court in a case filed by Japanese firm Daiichi Sankyo.
-
"Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
-
Fortis Co-Founder Shivinder Singh Sues Elder Brother For "Mismanagement"
Billionaire Shivinder Mohan Singh, co-founder of hospital chain Fortis Healthcare and former Ranbaxy promoter, has filed a case against his elder brother Malvinder Mohan Singh alleging "oppression and mismanagement" at their joint businesses - RHC Holding, Religare and Fortis.
-
Daiichi Sankyo Asks ED To Probe Singh Brothers' Transactions: A Timeline
Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.
-
Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal
Mumbai-based Sun Pharma will acquire troubled Indian drug maker Ranbaxy in a US$ 4 billion all-stock transaction, the company said in a statement on Monday.
-
Ranbaxy, Teva settle New York antitrust drug claims
Generic drug makers Ranbaxy of India and Teva of Israel have agreed to settle allegations they made an illegal pact to restrict competition in New York state.
